Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic vs Local Nalbuphine for Hand Surgery Pain
NCT03150732Completed
- Sponsor
- Assiut University
- Start
- Aug 2022
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of nalbuphine in postoperative pain, sponsored by Assiut University. Primary endpoint: Duration of postoperative Analgesia at 24 hours. Started Aug 2022; status: completed.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03150732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03150732.